Citation Impact
Citing Papers
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
2016 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Genetic basis of renal cellular dysfunction and the formation of kidney stones
2009
Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders
1998
Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
2012
Outcome of Extracorporeal Shockwave Lithotripsy Monotherapy for Large Renal Calculi: Effect of Stone and Collecting System Surface Areas and Cost-Effectiveness of Treatment
1995
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
A Systematic Review and Meta-analysis of Adjuvant and Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma
2014
2007 Guideline for the Management of Ureteral Calculi
2007 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Open stone surgery: Is it still a preferable procedure in the management of staghorn calculi?
1994
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
1998
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
EAU Guidelines on Interventional Treatment for Urolithiasis
2015 Standout
Upper tract urothelial carcinoma: Impact of time to surgery
2010
Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer
2006
EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis
2015 Standout
Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC)
2011
Clinical imaging of cancer metastasis
2000
Carcinoma of the upper urinary tract
2009
Stent Use with Extracorporeal Shock Wave Lithotripsy
1993
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy
2010
Single Upper-Pole Percutaneous Access for Treatment of ≥5-cm Complex Branched Staghorn Calculi: Is Shockwave Lithotripsy Necessary?
2002
Complete Staghorn Calculi: Random Prospective Comparison Between Extracorporeal Shock Wave Lithotripsy Monotherapy and Combined With Percutaneous Nephrostolithotomy
1997
Effects of Shock Waves on the Mouse Fetus
1994
Stone Surface Area Determination Techniques: A Unifying Concept of Staghorn Stone Burden Assessment
1992
CHAPTER 1: AUA GUIDELINE ON MANAGEMENT OF STAGHORN CALCULI: DIAGNOSIS AND TREATMENT RECOMMENDATIONS
2005 Standout
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
2001 Standout
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
1997
Vanilloid (Capsaicin) Receptors and Mechanisms
1999 Standout
Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma
2014
Preoperative Hydronephrosis Grade Independently Predicts Worse Pathological Outcomes in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Carcinoma
2011
The Effects of Extracorporeal Shock Wave Lithotripsy on Renal Growth, Function and Arterial Blood Pressure in an Animal Model
1991
Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.
1997
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer
2000
Kidney Stone Disease: An Update on Current Concepts
2018 Standout
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II
2016 Standout
The overactive bladder: Pharmacologic basis of drug treatment
1997
Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
2012
Staghorn Calculi: Analysis of Treatment Results between Initial Percutaneous Nephrostolithotomy and Extracorporeal Shock Wave Lithotripsy Monotherapy with Reference to Surface Area
1992
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Minimally invasive treatment of infection staghorn stones with shock wave lithotripsy and chemolysis.
1999
Works of C. Constantinides being referenced
Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: Comparison with dna ploidy
1995
Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the Lungs
1989
Morphological changes following ESWL in the rat kidney
1989
Adjuvant Chemotherapy With Paclitaxel and Carboplatin in Patients With Advanced Carcinoma of the Upper Urinary Tract: A Study by the Hellenic Cooperative Oncology Group
2004
Extracorporeal Shock Wave Lithotripsy as Monotherapy of Staghorn Renal Calculi: 3 Years of Experience
1989
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival.
2011
Determination of Interferon-alpha Receptors in Urothelial Cancer and in Normal Urothelium
1997